Stock Analysis | ResMed Outlook
– ResMed (RMD.N) fell 5.04% recently but maintains strong fundamentals and positive analyst ratings (3.88 average score), suggesting long-term resilience despite mixed technical indicators.
– Technical signals show RSI and Williams %R in oversold territory, indicating potential rebounds, though overall momentum remains neutral with no clear trend direction.
– Fund-flow trends are negative (7.85 score), with large investors showing slight optimism (49.38% inflow), contrasting small investors’ net outflows and bearish sentiment.
– Analysts recommend waiting for a pullback or breakout before large investments, emphasizing close monitoring of RSI/Williams %R for actionable entry/exit cues.
